Table 3. Clinical parameters associated with baseline Gal-3 plasma levels in AF patients.
Variables | UV | MV* | Model 1 | MV | Model 2 | |
---|---|---|---|---|---|---|
Beta | P-value | Beta | P-value | Beta | P-value | |
Age | .167 | 0.088 | ||||
Females | .215 | 0.028 | .165 | 0.081 | ||
Persistent AF | .076 | 0.438 | ||||
BMI | .274 | 0.005 | .203 | 0.040 | .235 | 0.016 |
eGFR | -.080 | 0.422 | ||||
LAD | .045 | 0.652 | ||||
LVEF | .021 | 0.831 | ||||
CHADS2 | .259 | 0.008 | .174 | 0.077 | ||
CHA2DS2-VASc | .234 | 0.016 | .185 | 0.055 |